• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Kidney Transplantation From a Hepatitis C Virus-Infected Donor Into an Uninfected Recipient: Ready for Prime Time?

作者信息

Pagan Javier, Ladino Marco, Roth David

机构信息

Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, Florida, USA.

Nephrology Section, Miami Veterans Administration Healthcare System, Miami, Florida, USA.

出版信息

Kidney Int Rep. 2020 Feb 11;5(4):386-388. doi: 10.1016/j.ekir.2020.02.001. eCollection 2020 Apr.

DOI:10.1016/j.ekir.2020.02.001
PMID:32281985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7136429/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee53/7136429/835ecf608c32/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee53/7136429/835ecf608c32/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee53/7136429/835ecf608c32/gr1.jpg

相似文献

1
Kidney Transplantation From a Hepatitis C Virus-Infected Donor Into an Uninfected Recipient: Ready for Prime Time?丙型肝炎病毒感染供体向未感染受体的肾移植：时机成熟了吗？
Kidney Int Rep. 2020 Feb 11;5(4):386-388. doi: 10.1016/j.ekir.2020.02.001. eCollection 2020 Apr.
2
Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.从丙型肝炎病毒感染供体向未感染受者移植肾脏：KDIGO 2022 丙型肝炎临床实践指南更新的系统评价。
Am J Kidney Dis. 2023 Oct;82(4):410-418. doi: 10.1053/j.ajkd.2022.12.019. Epub 2023 Apr 14.
3
Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States.美国供体和受体丙型肝炎感染对肾移植结果的影响分析。
World J Transplant. 2023 Feb 18;13(2):44-57. doi: 10.5500/wjt.v13.i2.44.
4
Risks, benefits, and ethical questions associated with transplanting kidneys from hepatitis C virus-infected donors into hepatitis C virus-negative patients.将丙型肝炎病毒感染供体的肾脏移植给丙型肝炎病毒阴性患者所涉及的风险、益处及伦理问题。
Semin Dial. 2019 Mar;32(2):179-186. doi: 10.1111/sdi.12767. Epub 2018 Nov 26.
5
Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation.使用艾尔巴韦和格拉瑞韦对丙型肝炎病毒血症供体至未感染受体的肾移植进行抢先治疗。
Kidney Int Rep. 2020 Jan 13;5(4):459-467. doi: 10.1016/j.ekir.2020.01.001. eCollection 2020 Apr.
6
Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains.丙型肝炎病毒感染供肝的肝移植：供体与受体病毒株之间的相互作用
Hepatology. 2003 Jul;38(1):25-33. doi: 10.1053/jhep.2003.50264.
7
Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.将丙型肝炎病毒感染与未感染的肾脏移植到丙型肝炎病毒感染的受者体内：成本效益分析。
Ann Intern Med. 2018 Aug 21;169(4):214-223. doi: 10.7326/M17-3088. Epub 2018 Jul 10.
8
Kidney Transplantation from a Hepatitis C Virus-positive Donor to a Hepatitis C Virus-negative Recipient.丙型肝炎病毒阳性供体至丙型肝炎病毒阴性受体的肾移植
Indian J Nephrol. 2018 Nov-Dec;28(6):488-489. doi: 10.4103/ijn.IJN_267_17.
9
Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.临床医生对丙型肝炎病毒阳性供体肾移植的意见调查：识别和克服障碍。
Kidney360. 2020 Nov;1(11):1291-1299. doi: 10.34067/KID.0004592020. Epub 2020 Nov 25.
10
Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.丙型肝炎病毒与肾移植：最新趋势与观念转变。
Transplant Rev (Orlando). 2022 Jan;36(1):100677. doi: 10.1016/j.trre.2021.100677. Epub 2022 Jan 4.

引用本文的文献

1
Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.临床医生对丙型肝炎病毒阳性供体肾移植的意见调查：识别和克服障碍。
Kidney360. 2020 Nov;1(11):1291-1299. doi: 10.34067/KID.0004592020. Epub 2020 Nov 25.

本文引用的文献

1
Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation.使用艾尔巴韦和格拉瑞韦对丙型肝炎病毒血症供体至未感染受体的肾移植进行抢先治疗。
Kidney Int Rep. 2020 Jan 13;5(4):459-467. doi: 10.1016/j.ekir.2020.01.001. eCollection 2020 Apr.
2
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者：真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
3
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
直接作用抗病毒药物时代丙型肝炎病毒供体对丙型肝炎病毒阳性受者肾移植结局的影响：是否需要修订肾脏供体风险指数？
Transplantation. 2020 Jun;104(6):1215-1228. doi: 10.1097/TP.0000000000002949.
4
Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.从丙型肝炎感染供体向丙型肝炎阴性受者移植肾脏：单中心经验。
Am J Transplant. 2019 Nov;19(11):3046-3057. doi: 10.1111/ajt.15530. Epub 2019 Aug 2.
5
Treating hepatitis C virus in dialysis patients: How, when, and why?透析患者丙型肝炎病毒的治疗：如何治疗、何时治疗以及为何治疗？
Semin Dial. 2019 Mar;32(2):152-158. doi: 10.1111/sdi.12764. Epub 2018 Nov 26.
6
Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.感染 HCV 的供肾移植至未感染受者后 12 个月的结果：单组试验。
Ann Intern Med. 2018 Sep 4;169(5):273-281. doi: 10.7326/M18-0749. Epub 2018 Aug 7.
7
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.直接作用抗病毒预防在丙型肝炎病毒感染供体向非感染受者的肾移植中的应用：一项开放标签非随机试验。
Ann Intern Med. 2018 Apr 17;168(8):533-540. doi: 10.7326/M17-2871. Epub 2018 Mar 6.
8
Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic.提高器官利用率以助力克服阿片类药物流行带来的悲剧。
Am J Transplant. 2016 Oct;16(10):2836-2841. doi: 10.1111/ajt.13971. Epub 2016 Aug 24.
9
Transplanting Hepatitis C-Positive Kidneys.移植丙型肝炎阳性肾脏。
N Engl J Med. 2015 Jul 23;373(4):303-5. doi: 10.1056/NEJMp1505074.